- Home
- OABI vs GRAL Comparison
OABI vs GRAL Comparison
Compare OABI & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- GRAL
- Stock Information
- Founded
- OABI 2012
- GRAL 2016
- Country
- OABI United States
- GRAL United States
- Employees
- OABI N/A
- GRAL N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- OABI Health Care
- GRAL
- Exchange
- OABI Nasdaq
- GRAL NYSE
- Market Cap
- OABI 459.1M
- GRAL 449.6M
- IPO Year
- OABI N/A
- GRAL N/A
- Fundamental
- Price
- OABI $3.85
- GRAL $16.38
- Analyst Decision
- OABI Strong Buy
- GRAL Hold
- Analyst Count
- OABI 4
- GRAL 1
- Target Price
- OABI $9.00
- GRAL N/A
- AVG Volume (30 Days)
- OABI 509.5K
- GRAL 603.0K
- Earning Date
- OABI 11-12-2024
- GRAL 11-12-2024
- Dividend Yield
- OABI N/A
- GRAL N/A
- EPS Growth
- OABI N/A
- GRAL N/A
- EPS
- OABI N/A
- GRAL N/A
- Revenue
- OABI $20,409,000.00
- GRAL $117,669,000.00
- Revenue This Year
- OABI N/A
- GRAL N/A
- Revenue Next Year
- OABI $71.78
- GRAL N/A
- P/E Ratio
- OABI N/A
- GRAL N/A
- Revenue Growth
- OABI N/A
- GRAL 111.83
- 52 Week Low
- OABI $3.56
- GRAL $12.33
- 52 Week High
- OABI $6.72
- GRAL $23.36
- Technical
- Relative Strength Index (RSI)
- OABI 40.94
- GRAL N/A
- Support Level
- OABI $3.62
- GRAL N/A
- Resistance Level
- OABI $4.19
- GRAL N/A
- Average True Range (ATR)
- OABI 0.23
- GRAL 0.00
- MACD
- OABI -0.06
- GRAL 0.00
- Stochastic Oscillator
- OABI 18.40
- GRAL 0.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.